The Role of Next-Generation Sequencing (NGS) in the Management of Tuberculosis: Practical Review for Implementation in Routine
- PMID: 37623938
- PMCID: PMC10459500
- DOI: 10.3390/pathogens12080978
The Role of Next-Generation Sequencing (NGS) in the Management of Tuberculosis: Practical Review for Implementation in Routine
Abstract
Next-generation sequencing (NGS) has modernized the field of tuberculosis (TB) research by enabling high-throughput sequencing of the entire genome of Mycobacterium tuberculosis (MTB), which is the causative agent of TB. NGS has provided insights into the genetic diversity of MTB, which are crucial for understanding the evolution and transmission of the disease, and it has facilitated the identification of drug-resistant strains, enabling rapid and accurate tailoring of treatment. However, the high cost and the technical complexities of NGS currently limit its widespread use in clinical settings. International recommendations are thus necessary to facilitate the interpretation of polymorphisms, and an experimental approach is still necessary to correlate them to phenotypic data. This review aims to present a comparative, step-by-step, and up-to-date review of the techniques available for the implementation of this approach in routine laboratory workflow. Ongoing research on NGS for TB holds promise for improving our understanding of the disease and for developing more efficacious treatments.
Keywords: antibiotic resistance; next-generation sequencing; tuberculosis.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Best approaches to drug-resistance surveillance at the country level.Int J Mycobacteriol. 2016 Dec;5 Suppl 1:S40-S41. doi: 10.1016/j.ijmyco.2016.09.010. Epub 2016 Oct 21. Int J Mycobacteriol. 2016. PMID: 28043601
-
Next-generation sequencing-based user-friendly platforms for drug-resistant tuberculosis diagnosis: A promise for the near future.Int J Mycobacteriol. 2016 Dec;5 Suppl 1:S27-S28. doi: 10.1016/j.ijmyco.2016.09.021. Epub 2016 Oct 28. Int J Mycobacteriol. 2016. PMID: 28043592
-
Resistance Sniffer: An online tool for prediction of drug resistance patterns of Mycobacterium tuberculosis isolates using next generation sequencing data.Int J Med Microbiol. 2020 Feb;310(2):151399. doi: 10.1016/j.ijmm.2020.151399. Epub 2020 Jan 17. Int J Med Microbiol. 2020. PMID: 31980371
-
Whole genome sequencing for drug-resistant tuberculosis management in South Africa: What gaps would this address and what are the challenges to implementation?J Clin Tuberc Other Mycobact Dis. 2019 Jul 9;16:100115. doi: 10.1016/j.jctube.2019.100115. eCollection 2019 Aug. J Clin Tuberc Other Mycobact Dis. 2019. PMID: 31720436 Free PMC article. Review.
-
[Development of antituberculous drugs: current status and future prospects].Kekkaku. 2006 Dec;81(12):753-74. Kekkaku. 2006. PMID: 17240921 Review. Japanese.
Cited by
-
Assistance of next-generation sequencing for diagnosis of disseminated Bacillus Calmette-Guerin disease with X-SCID in an infant: a case report and literature review.Front Cell Infect Microbiol. 2024 Feb 12;14:1341236. doi: 10.3389/fcimb.2024.1341236. eCollection 2024. Front Cell Infect Microbiol. 2024. PMID: 38410723 Free PMC article. Review.
-
Case report: Difficult diagnosis of Mycobacterium tuberculosis infection in patients after allogeneic hematopoietic stem cell transplantation: two case reports and a literature review.Front Oncol. 2024 May 28;14:1283320. doi: 10.3389/fonc.2024.1283320. eCollection 2024. Front Oncol. 2024. PMID: 38863639 Free PMC article.
-
Point-of-care testing of rpoB in Mycobacterium tuberculosis using multiply-primed-RCA coupled with CRISPR/Cas12a.Heliyon. 2024 Sep 7;10(18):e37640. doi: 10.1016/j.heliyon.2024.e37640. eCollection 2024 Sep 30. Heliyon. 2024. PMID: 39309806 Free PMC article.
-
Evidence of Mycobacterium bovis DNA in shared water sources at livestock-wildlife-human interfaces in KwaZulu-Natal, South Africa.Front Vet Sci. 2025 Feb 28;12:1483162. doi: 10.3389/fvets.2025.1483162. eCollection 2025. Front Vet Sci. 2025. PMID: 40093619 Free PMC article.
-
Nanopore-based targeted sequencing (NTS) for drug-resistant tuberculosis: an integrated tool for personalized treatment strategies and guidance for new drug development.BMC Infect Dis. 2025 Jul 1;25(1):861. doi: 10.1186/s12879-025-11227-4. BMC Infect Dis. 2025. PMID: 40596923 Free PMC article.
References
-
- Tuberculosis (TB) [(accessed on 21 June 2023)]. Available online: https://www.who.int/news-room/fact-sheets/detail/tuberculosis.
-
- Catalogue of Mutations in Mycobacterium tuberculosis Complex and Their Association with Drug Resistance. [(accessed on 20 July 2022)]. Available online: https://www.who.int/publications-detail-redirect/9789240028173.
-
- Cepheid-Xpert-MTB-RIF-Ultra-Comparison-Flyer-CE-IVD-3094-French.Pdf. [(accessed on 31 May 2023)]. Available online: http://cepheid.widen.net/content/x3dru1nudu/pdf/Cepheid-Xpert-MTB-RIF-Ul....
-
- MTB-RIF-Dx-packinsert-V05.pdf. [(accessed on 31 May 2023)]. Available online: https://wwwmolbiodiagnostics.com/uploads/product_download/20220502.10560...
-
- BD MAXTM MDR-TB. [(accessed on 31 May 2023)]. Available online: https://www.bd.com/resource.aspx?IDX=35759.
Publication types
LinkOut - more resources
Full Text Sources
Molecular Biology Databases